Val-Cit-PAB-MMAE(644981-35-1)
- Name: Val-Cit-PAB-MMAE
- Synonyms:Val-Cit-PAB-MMAE;4H-1-Benzopyran-4-one,7-hydroxy-4-(trifluoromethyl)-;Drug-Linker Conjugates for ADC,inhibit,Inhibitor,Val Cit PAB MMAE,ValCitPABMMAE;4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate;VCPMMAE;Val-Cit-PAB-MMAE, 10 mM in DMSO;N-Methyl-N-[[[4-[[L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
- Molecular Formula:C58H94N10O12
- Molecular Weight:1123.43
- CAS Registry Number:644981-35-1
- EINECS:
- Melting Point:1211.860±65.00 °C(Press: 760.00 Torr)(predicted)
- Water Solubility:
Other Product
- 643761-57-3/(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[(4-phenylmethoxyphenyl)methyl]piperidine-3,4,5-triol
- 6437-62-3/2-Propanone, 1-(3-methoxyphenoxy)-, oxime
- 643766-82-9/1-Propanesulfonyl fluoride, 2,2,3,3,3-pentafluoro-
- 64389-33-9/Ethyl 5-(4-((tert-butoxycarbonyl)amino)phenyl)isoxazole-3-carboxylate
- 64394-40-7/2-(3,4-dimethylphenyl)propanal
- 6440-03-5/Tert-butyl 5-amino-1,2,3-thiadiazole-4-carboxylate
- 644174-54-8/(-)3-BromoCamphor
- 64426-16-0/sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate heptahydrate
- 64449-02-1/Tungsten, dicarbonylchloro(η5-2,4-cyclopentadien-1-yl)(methylimidodiphosphorous tetrafluoride-κP)- (9CI)
- 64462-98-2/6-Quinolinebutanoic acid, 1,2,3,4-tetrahydro-γ-hydroxy-2-oxo-
- 64463-49-6/1-Dodecanaminium, N,N-dimethyl-N-(4-sulfobutyl)-, inner salt
- 644950-35-6/methyl({[4-(trifluoromethyl)-1,3-thiazol-2-yl]methyl})amine
- 644950-96-9/2H-Pyrimido[4,5-b]azepine-2-thione,4-ethyl-1,3,5,6,7,8-hexahydro-(9CI)
- 644954-37-0/Propanamide, N-(2,4-difluorophenyl)-3-[(4-methylphenyl)thio]-
- 644962-95-8/2’-O-Methyl-pyrrolo C CEP
- 644968-84-3/Benzamide, N-cyclopropyl-2-hydroxy-4-methoxy-
- 644969-12-0/Benzamide, N-cyclopropyl-2-hydroxy-4-[(4-methoxyphenyl)methoxy]-
- 644972-97-4/Benzamide, N-(5-chloro-2,4-dihydroxyphenyl)-
- 644977-33-3/1,4-Dioxino[2,3-b]pyridine-3-methanol, 6-bromo-2,3-dihydro-
- 644981-35-1/Val-Cit-PAB-MMAE
- 644990-45-4/phenyl 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2-carboxylate
- 644990-48-7/CBI-BB ZERO/005042
- 644994-86-5/1,1,1-trifluoro-3,3-diiodopropan-2-one
- 644996-12-3/1-Pyrrolidineacetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, ethyl ester, (4R)-
- 64507-19-3/Benzenepropanoic acid, 4-[2-(methylamino)ethyl]-, hydrochloride (1:1)
- 6451-07-6/5-[[4-[[8-Amino-1-hydroxy-7-(phenylazo)-3,5-bis(sodiosulfo)-2-naphthalenyl]azo]-1-naphthalenyl]azo]-2-hydroxybenzoic acid sodium salt
- 64514-49-4/Titanium, oxo[sulfato(2-)-κO]-, hydrate (1:)
- 64521-08-0/Calcium sulfonates
- 645348-95-4/(Z)-N-((1H-indol-3-yl)methylene)-4-bromoaniline oxide
- 645358-95-8/Carbamic acid, [(1S)-2-hydroxy-1-[(4-hydroxyphenyl)methyl]ethyl]-, 9H-fluoren-9-ylmethyl ester (9CI)
